JW Therapeutics Announces NMPA Acceptance of the Supplemental Biological License Application for Carteyva® in Patients with Relapsed or Refractory Mantle Cell Lymphoma

JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced that the National Medical Products Administration (NMPA) of China accepted the supplemental Biological License Application (sBLA) for its anti-CD19 autologous chimeric antigen receptor T (CAR-T) cell immunotherapy product Carteyva® (relmacabtagene autoleucel injection)…

thaipr.net

5 ม.ค. 67

UnionPay International Partners with Trip.com to Provide Global Travelers with Enhanced Payment Experiences

UnionPay International (“UPI” or “the Company”) recently partnered with Trip.com, the world’s leading online travel agency (OTA), to provide UnionPay cardholders an enhanced payment experience in a partnership that coincides with the gradual recovery of the cross-border tourism market. The cooperation covers all major transaction currencies on Trip.com’s global sites accepting UnionPay online payment, include…

thaipr.net

15 ธ.ค. 66

Shanghai Electric’s Efforts Included in 2023 ESG Excellent Cases of Chinese Public Companies

Shanghai Electric (SEHK:2727, SSE:601727) was honored at the Chinese Listed Companies Sustainable Development Conference for its remarkable performance in Environmental, Social, and Governance (ESG). Included in the “2023 ESG Excellent Cases of Chinese Public Companies”, the company’s progressive strategies and unique insights have significantly contributed to the transformation of the ESG landscape in China. The […]

thaipr.net

1 ธ.ค. 66
1 2 3 4 37